Synthesis and carbonic anhydrase isoenzymes i and II inhibitory effects of novel benzylamine derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 2, 2014, Pages 168-174

  Çetinkaya, Yasin ^a   Göçer, Hülya ^b   Göksu, Süleyman ^a   Gülçin, Ilhami ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

^b AGRI IBRAHIM CECEN UNIVERSITY   (Turkey)

Author keywords

Benzylamine; Carbonic anhydrase; Enzyme inhibition; Sulfonamide

Indexed keywords

(2,3 DIMETHOXYPHENYL) (3,4 DIMETHOXYPHENYL) METHANAMINE; (2,4 DIMETHOXYPHENYL) (3,4 DIMETHOXYPHENYL) METHANAMINE; (3,4 DIMETHOXYPHENYL) METHANAMINE; (4,5 DIMETHOXY 2 METHYLPHENYL) (3,4 DIMETHOXYPHENYL) METHANAMINE; ACETAZOLAMIDE; ALCOHOL DERIVATIVE; AZIDE; BENZENE; BENZYLAMINE DERIVATIVE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBOXYLIC ACID; DIARYLMETHYLAMINE DERIVATIVE; KETONE; N ((2,3 DIMETHOXYPHENYL) (3,4 DIMETHOXYPHENYL) METHYL) METHANE; N [(4,5 DIMETHOXY 2 METHYLPHENYL) (3,4 DIMETHOXYPHENYL) METHYL) METHANE SULFONAMIDE; N [BIS (3,4 DIMETHOXYPHENYL) METHYL] METHANESULFONAMIDE; PALLADIUM; SULFONAMIDE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HYDROGENATION; PRIORITY JOURNAL;

BENZYLAMINES; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; SULFONAMIDES;

EID: 84896379999     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.763163     Document Type: Article

References (50)

1. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000;10:575-601.
2. Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms. Chem Rev 2012;112:4421-68.
3. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81.
4. Alterio V, De Simone G, Monti SM, et al. Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3- disulfonamides - solution and crystallographic studies. Bioorg Med Chem Lett 2007;17:4201-7.
5. Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm 2002;248:1-14.
6. Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007;116:322-7.
7. Supuran CT. Carbonic anhydrases-an overview. Curr Pharm Des 2008;14:603-14.
8. Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulphonamides. Curr Pharm Des 2008;14:641-8.
9. Sjoublom B, Polentarutti M, Djinovic-Carugo K. Structural study of X-ray induced activation of carbonic anhydrase. Proc Natl Acad Sci USA 2009;106:10609-13.
10. Senturk M, Gulcin I, Dastan A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207-11.
11. Clare BW, Supuran CT. A perspective on quantitative structureactivity relationships and carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2006;2:113-37.
12. Coban TA, Beydemir S, Gulcin I, Ekinci D. Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo. Biol Pharm Bull 2007;30:2257-61.
13. Innocenti A, Hilvo M, Scozzafava A, et al. Carbonic anhydrase inhibitors: inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 2008;18:3593-6.
14. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 1997;74:1-20.
15. Ozturk Sarikaya SB, Topal F, Senturk M, et al. In vitro inhibition of a-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259-62.
16. Supuran CT, Scozzafava A, Conway J. Carbonic anhydrase: its inhibitors and activators. Boca Raton (FL): CRC Press; 2004:243-54.
17. Supuran CT. Carbonic anhydrases as drug targets-an overview. Curr Top Med Chem 2007;7:825-33.
18. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-50.
19. Innocenti A, Gulcin I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenol natural products effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 2010;20:5050-3.
20. Alterio V, Di Fiore A, D'Ambrosio K, et al. X-ray crystallography of CA inhibitors and its importance in drug design. In: Supuran CT, Winum JY, eds. In drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken (NJ): Wiley; 2009:73-138.
21. Duda DM, Tu C, Fisher SZ, et al. Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer. Biochemistry 2005;44:10046-53.
22. Di Fiore A, Monti M, Hilvo MS, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2008;74:164-75.
23. Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233-8.
24. Harig M, Neumann B, Stammler HG, Kuck D. 2,3,6,7,10,11- Hexamethoxytribenzo-triquinacene: synthesis, solid-state structure and functionalization of a rigid analogue of cyclotriveratrylene. Eur J Org Chem 2004;11:2381-97.
25. Mitter PC. Some derivatives of 4-phenylchroman. J Ind Chem Soc 1931;8:271-6.
26. Garofano T, Oliverio A. The influence of o-substituents on the reactivity of aryl ketones. I. Influence of o-substituents on the reactivity of benzophenone. Annal di Chim 1957;47:260-84.
27. Gazave JM, Rancurel A, Grenier G. Pharmaceutical composition containing at least one diphenyl-substituted compound. Ger Offen Patent 1975, DE 2501443. Chem Abstr 1975;83:188522.
28. Konig B, Kostanecki Sv. Leuco-compounds of hydroxyketones. Ber Deutsch Chem Gesellschaft 1907;39:4027-31.
29. Fukazawa N, Odate M, Suzuki T, et al. Preparation of heterocyclic compounds as anticancer drug potentiators. Eur Patent Appl 1990, Chem Abstr 1990;113:152275.
30. Valette. Mono- and polyalkyl- or halogen-substituted derivatives of benzohydrylamine and symmetrical diphenylethylamine. Bull Soc Chim Fr 1930;47:289-300.
31. Ozturk Sarikaya SB, Gulcin I, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem Biol Drug Design 2010;75:515-20.
32. Senturk M, Gulcin I, Beydemir S, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Design 2011;77:494-9.
33. Gulcin I, Beydemir S, Buyukokuroglu ME. In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biol Pharm Bull 2004;27:613-16.
34. Beydemir S, Gulcin I. Effect of melatonin on carbonic anhydrase from human erythrocyte in vitro and from rat erythrocyte in vivo. J Enzyme Inhib Med Chem 2004;19:193-7.
35. Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem 1976;176:147-54.
36. Aras Hisar S, Hisar O, Beydemir S, et al. Effect of vitamin E on carbonic anhydrase enzyme activity in rainbow trout (Oncorhynchus mykiss) erythrocytes in vitro and in vivo. Acta Vet Hung 2004;52:413-22.
37. Verpoorte JA, Metha S, Edsall JT. Esterase activities of human carbonic anhydrase B and C. J Biol Chem 1967;242:4221-9.
38. Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;57:685-93.
39. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
40. Gulcin I, Kufrevioglu OI, Oktay M. Purification and characterization of polyphenol oxidase from nettle (Urtica dioica L.) and inhibition effects of some chemicals on the enzyme activity. J Enzyme Inhib Med Chem 2005;20:297-302.
41. Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
42. Cetinkaya Y, Menzek A, Sahin E, Balaydin HT. Selective O-demethylation during bromination of (3,4-dimethoxyphenyl) (2,3,4-trimethoxyphenyl)methanone. Tetrahedron 2011;67: 3483-9.
43. Cetinkaya Y, Gocer H, Menzek A, Gulcin I. Synthesis and antioxidant properties of (3,4-dihydroxyphenyl)(2,3,4- trihydroxyphenyl)methanone and its derivatives. Arch Pharm Chem Life Sci 2011;345:323-34.
44. Nar M, Cetinkaya Y, Gulcin I, Menzek A. (3,4- Dihydroxyphenyl)(2,3,4- trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. J Enzyme Inhib Med Chem 2012. [Epub ahead of print]. doi: 10.3109/ 14756366.2012.670807.
45. Balaydin HT, Akbaba Y, Menzek A, et al. First and short syntheses of biologically active, naturally occurring brominated mono- and dibenzyl phenols. Arkivoc 2009;14:75-87.
46. Hosangadi BD, Kasbekar AB, Nabar MJ, Desai RC. Novel reactions with polyphosphoric acid II. Decarboxylative acetylation, transcarbonylation, and other reactions of substituted aromatic carboxylic acids. Ind J Chem 1973;11:711-13.
47. Lantano B, Aguirre JM, Ugliarolo EA, et al. Scope of the formal [3+2] cycloaddition for the synthesis of five-membered ring of functionalized indanes. Tetrahedron 2012;68:913-21.
48. Goksu S, Secen H, Sutbeyaz Y. One-pot and stereospecific synthesis of cis-1,2-diazides via Mitsunobu reaction of epoxides. Synthesis- Stuttgart 2002;16:2373-8.
49. Goksu S, Secen H. Concise syntheses of 2-aminoindans via indan-2- ol. Tetrahedron 2005;61:6801-7.
50. Pastorekova S, Vullo D, Nishimori I, et al. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg Med Chem 2008;16:3530-6.